The Thoroughbred Owners and Breeders Association announced Jan. 20 that EquStem has become an official marketing partner of the company.
EquStem is an equine stem cell bank that provides collection and storage of stem cells using umbilical cord blood collection. Collected stem cells are cryogenically frozen for potential use at a later date. Stem cells can be utilized to aid in the recovery of tendon, ligament and joint injuries.
“We are excited to partner with EquStem, a new and innovative company that is working to utilize emerging laboratory technologies to aid injured Thoroughbreds in the recovery and healing process” said Dan Metzger, president of TOBA, in a statement.
Dr. Jerry Grossman, president of EquStem said, “EquStem, like TOBA, believes it has a social responsibility to educate and enhance the treatment and care of Thoroughbreds, thus improving the sport and lives of these athlete horses. EquStem looks forward to continuing to provide technically advanced equine stem cell services to the Thoroughbred and horse breeding community.”
EquStem was formed in early 2008 as the first commercial equine umbilical cord blood derived stem cell bank in the United States.
Headquartered in Hackensack, N.J. with laboratories in Allendale, N.J., EquStem’s technical facilities are located near five major airports ensuring ease of access to its processing and storage facilities. More information can be found at www.equstem.com.
